Compare IRM & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRM | RMD |
|---|---|---|
| Founded | 1951 | 1989 |
| Country | United States | United States |
| Employees | N/A | 10600 |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.4B | 28.4B |
| IPO Year | 1997 | N/A |
| Metric | IRM | RMD |
|---|---|---|
| Price | $125.34 | $195.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 10 |
| Target Price | $122.50 | ★ $292.56 |
| AVG Volume (30 Days) | ★ 1.8M | 1.6M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.02% | 1.13% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $4,491,531,000.00 | N/A |
| Revenue This Year | $13.30 | $10.60 |
| Revenue Next Year | $9.31 | $7.41 |
| P/E Ratio | $259.06 | ★ $25.61 |
| Revenue Growth | ★ 8.30 | N/A |
| 52 Week Low | $77.77 | $180.27 |
| 52 Week High | $134.68 | $293.81 |
| Indicator | IRM | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.43 | 45.98 |
| Support Level | $122.22 | $190.25 |
| Resistance Level | $133.17 | $197.41 |
| Average True Range (ATR) | 4.09 | 6.32 |
| MACD | 0.48 | -0.77 |
| Stochastic Oscillator | 82.05 | 18.83 |
Iron Mountain Inc is an information management services provider organized and operated as a real estate investment trust. The company offers solutions to its clients to address their information management, digital transformation, information security, data center, and asset lifecycle management (ALM) needs. Its customers come from various industries, including commercial, legal, financial, healthcare, technology, etc. The company has two reportable segments: Global Records and Information Management (Global RIM) and Global Data Center. Maximum revenue is generated from the Global RIM segment, which offers data and records management, secure shredding, consumer storage, and other related services. Geographically, the company generates maximum revenue from the United States.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.